1-11 of 11
Robert K. Bright
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4791: Inhibition of Tumor Formation in Mice following Vaccination with DNA Encoding a Novel Xenogeneic Tumor Associated Auto-Antigen

Robert K. Bright, Jennifer D. Bright, Heather N. Schultz
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 4791.
https://doi.org/10.1158/1538-7445.AM10-4791
Published: 15 April 2010
View article titled, Abstract 4791: Inhibition of Tumor Formation in Mice following Vaccination with DNA Encoding a Novel Xenogeneic Tumor Associated Auto-Antigen
Journal Articles

Abstract 2338: Molecular mechanisms underlying cellular transformation by Tumor protein D52 overexpression

Austin Della-Franca, Daniel R. Catchpoole, Robert K. Bright, Anna deFazio, Jennifer A. Byrne
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2338.
https://doi.org/10.1158/1538-7445.AM10-2338
Published: 15 April 2010
View article titled, Abstract 2338: Molecular mechanisms underlying cellular transformation by Tumor protein D52 overexpression
Journal Articles

Induction of tumorigeneis and metastasis by the murine homologue of tumor protein D52 (TPD52)

Jennifer D. Lewis, Laura A. Payton, Robert K. Bright
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1015.
Published: 15 April 2006
View article titled, Induction of tumorigeneis and metastasis by the murine homologue of tumor protein D52 (TPD52)
Journal Articles

Non-mutated self protein murine TPD52 (mD52) induces anti-tumor immunity following active vaccination

Robert K. Bright, Laura A. Payton, Jennifer D. Lewis
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 531.
Published: 15 April 2006
View article titled, Non-mutated self protein murine TPD52 (mD52) induces anti-tumor immunity following active vaccination
Journal Articles

Self antigen TPD52 and TLR9 ligand as a protein-based cancer vaccine

Robert K. Bright, Laura A. Payton, Jennifer D. Lewis
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1214.
Published: 01 May 2005
View article titled, Self antigen TPD52 and TLR9 ligand as a protein-based cancer vaccine
Journal Articles

Surrogate Tumor Antigen Vaccination Induces Tumor-Specific Immunity and the Rejection of Spontaneous Metastases

Jennifer D. Lewis, Michael H. Shearer, Ronald C. Kennedy, Robert K. Bright
Journal: Cancer Research
Cancer Res (2005) 65 (7): 2938–2946.
https://doi.org/10.1158/0008-5472.CAN-04-2874
Published: 01 April 2005
View article titled, Surrogate Tumor Antigen Vaccination Induces Tumor-Specific Immunity and the Rejection of Spontaneous Metastases
Open the PDF for Surrogate Tumor Antigen Vaccination Induces Tumor-Specific Immunity and the Rejection of Spontaneous Metastases in another window
Journal Articles

Surrogate tumor antigen (STA) surface expression may be required for cross-priming and induction of systemic tumor immunity following STA-based vaccination

Jennifer D. Lewis, Robert K. Bright
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1084.
Published: 01 April 2004
View article titled, Surrogate tumor antigen (STA) surface expression may be required for cross-priming and induction of systemic tumor immunity following STA-based vaccination
Journal Articles

CD4+ T Lymphocytes Play a Critical Role in Antibody Production and Tumor Immunity against Simian Virus 40 Large Tumor Antigen

Ronald C. Kennedy, Michael H. Shearer, Allison M. Watts, Robert K. Bright
Journal: Cancer Research
Cancer Res (2003) 63 (5): 1040–1045.
Published: 01 March 2003
View article titled, CD4+ T Lymphocytes Play a Critical Role in Antibody Production and Tumor Immunity against Simian Virus 40 Large Tumor Antigen
Open the PDF for CD4+ T Lymphocytes Play a Critical Role in Antibody Production and Tumor Immunity against Simian Virus 40 Large Tumor Antigen in another window
Journal Articles

Generation and Genetic Characterization of Immortal Human Prostate Epithelial Cell Lines Derived from Primary Cancer Specimens

Robert K. Bright, Cathy D. Vocke, Michael R. Emmert-Buck, Paul H. Duray, Diane Solomon, Patricia Fetsch, Johng S. Rhim, W. Marston Linehan, Suzanne L. Topalian
Journal: Cancer Research
Cancer Res (1997) 57 (5): 995–1002.
Published: 01 March 1997
View article titled, Generation and Genetic Characterization of Immortal Human Prostate Epithelial Cell Lines Derived from Primary Cancer Specimens
Open the PDF for Generation and Genetic Characterization of Immortal Human Prostate Epithelial Cell Lines Derived from Primary Cancer Specimens in another window
Journal Articles

Protection against a Lethal Tumor Challenge with SV40-transformed Cells by the Direct Injection of DNA-encoding SV40 Large Tumor Antigen

Robert K. Bright, Burton Beames, Michael H. Shearer, Ronald C. Kennedy
Journal: Cancer Research
Cancer Res (1996) 56 (5): 1126–1130.
Published: 01 March 1996
View article titled, Protection against a Lethal Tumor Challenge with SV40-transformed Cells by the Direct Injection of DNA-encoding SV40 Large Tumor Antigen
Open the PDF for Protection against a Lethal Tumor Challenge with SV40-transformed Cells by the Direct Injection of DNA-encoding SV40 Large Tumor Antigen in another window
Journal Articles

Comparison of Humoral Immune Responses and Tumor Immunity in Mice Immunized with Recombinant SV40 Large Tumor Antigen and a Monoclonal Anti-Idiotype

Michael H. Shearer, Robert K. Bright, Ronald C. Kennedy
Journal: Cancer Research
Cancer Res (1993) 53 (23): 5734–5739.
Published: 01 December 1993
View article titled, Comparison of Humoral Immune Responses and Tumor Immunity in Mice Immunized with Recombinant SV40 Large Tumor Antigen and a Monoclonal Anti-Idiotype
Open the PDF for Comparison of Humoral Immune Responses and Tumor Immunity in Mice Immunized with Recombinant SV40 Large Tumor Antigen and a Monoclonal Anti-Idiotype in another window